Applied dna to report first quarter fiscal 2023 financial results and host investor conference call and webcast on thursday, february 9, 2023
Stony brook, n.y.--(business wire)--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the “company”), a leader in polymerase chain reaction ("pcr")-based technologies, today announced that it will release financial results for the three months ended december 31, 2022, after the market closes on thursday, february 9, 2023. the company will host a conference call for the investment community to discuss its results and answer questions at 4:30 p.m. et. date & time: thursday, february 9 @ 4:30 p.m. et dial in (ask to be joined into the applied dna sciences call): domestic callers (toll free): 844-887-9402 canadian callers (toll free): 866-605-3852 international callers: 412-317-6798 live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=gz93pcbr a telephonic replay of the conference call will be available for 1 week following the conclusion of the live call: replay for domestic callers (toll free): 877-344-7529, replay access code 2079390 replay for canadian callers: 855-669-9658, replay access code 2079390 an archived webcast replay of the conference call will be available for 1 year following the conclusion of the live call: https://event.choruscall.com/mediaframe/webcast.html?webcastid=gz93pcbr an accompanying slide presentation will be embedded in the webcast (live and replay) and can also be accessed in the ‘company events’ section of the ‘news & events’ tab of the applied dna investor relations website at https://investors.adnas.com/. about applied dna sciences applied dna sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("dna"). using the polymerase chain reaction ("pcr") to enable both the production and detection of dna, we operate in three primary business markets: (i) the manufacture of dna for use in nucleic acid-based therapeutics; (ii) the detection of dna in molecular diagnostics testing services; and (iii) the manufacture and detection of dna for industrial supply chain security services. visit adnas.com for more information. follow us on twitter and linkedin. join our mailing list. the company's common stock is listed on nasdaq under the ticker symbol 'apdn,' and its publicly traded warrants are listed on otc under the ticker symbol 'appdw.'
APDN Ratings Summary
APDN Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission